Bourdow Carrie L.
Director at Nabriva Therapeutics AG
- Sold, on record
- $2k
- Dollars the filings state
- Form 4 sales
- 2
- Latest Aug 1, 2022
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Nabriva Therapeutics AGDirector
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Nabriva Therapeutics AGPlan not statedAug 2, 2021 2021
Sold 777 shares at $1.20 ($932)
Bourdow Carrie L., Director
Sold 4% of holdings ($23k position)18,473 shares leftFirst sale on recordFiling
- 2 Form 4 sale Nabriva Therapeutics AGUnusualAug 1, 2022 +364 days
Sold 8,540 shares at $0.17 ($1k)
Bourdow Carrie L., Director
Sold 46.2% of holdings ($3k position)9,933 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (2)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Aug 1, 2022 | Aug 3, 2022 | Nabriva Therapeutics AG | Director | Form 4 sale | 8,540 | $1k | 46.2% | Unusual | SEC |
| Aug 2, 2021 | Aug 4, 2021 | Nabriva Therapeutics AG | Director | Form 4 sale | 777 | $932 | 4.0% | Plan not stated | SEC |